Bio-Rad Release: Company To Report Fourth-Quarter And Full-Year 2016 Financial Results Thursday, February 23, 2017 Post author:Sam Post published:January 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Ipsen Announces FDA Approval Of Dysport (Abobotulinumtoxina) For The Treatment Of Lower Limb Spasticity In Adults June 15, 2017 Biotech Startup Elstar Therapeutics Closes $39M for New Immunotherapy Approach January 2, 2018 PAREXEL Sold to Investment Firm in $5 Billion Deal June 19, 2017
Ipsen Announces FDA Approval Of Dysport (Abobotulinumtoxina) For The Treatment Of Lower Limb Spasticity In Adults June 15, 2017